Novo Nordisk A/S

NONOF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$32,084$18,435$38,938$15,655
Short-Term Investments$499$499$2,612$10,653
Receivables$75,421$85,843$69,459$87,414
Inventory$47,504$45,652$42,853$40,849
Other Curr. Assets$26,375$12,276$20,533$6,326
Total Curr. Assets$181,883$162,705$174,395$160,897
Property Plant & Equip (Net)$193,244$180,758$172,376$162,488
Goodwill$0$0$0$20,064
Intangibles$106,587$107,866$109,379$91,026
Long-Term Investments$2,725$2,638$2,700$2,677
Tax Assets$0$23,747$26,275$24,627
Other NC Assets$27,849$4,439$4,037$4,016
Total NC Assets$330,405$319,448$314,767$304,898
Other Assets$0$0$0$0
Total Assets$512,288$482,153$489,162$465,795
Liabilities
Payables$23,904$28,206$19,576$28,846
Short-Term Debt$12,034$11,963$22,413$13,113
Tax Payable$0$16,927$15,501$9,716
Deferred Revenue$0$0$0$0
Other Curr. Liab.$198,420$150,426$178,627$165,853
Total Curr. Liab.$234,358$207,522$236,117$217,528
LT Debt$89,180$87,305$96,310$89,674
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$9,796$8,705$5,426
Other NC Liab.$18,854$9,464$9,490$9,681
Total NC Liab.$108,034$106,565$114,505$104,781
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$6,766
Total Liabilities$342,392$314,087$350,622$322,309
Equity
Pref Stock$0$0$0$0
Common Stock$446$446$446$446
Retained Earnings$168,529$164,453$137,319$144,448
AOCI$923$3,169$777-$1,406
Other Equity-$2-$2-$2-$2
Total Equity$169,896$168,066$138,540$143,486
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$512,288$482,153$489,162$465,795
Net Debt$69,130$80,833$79,785$87,132